Over 10 years we help companies reach their financial and branding goals. Maxbizz is a values-driven consulting agency dedicated.

Gallery

Contact

+1-800-456-478-23

411 University St, Seattle

maxbizz@mail.com

the street news image

EV Platform Market Valuation To Exceed US$ 97.3 Bn By 2030, Automakers To Adopt Modular EV Platforms To Reach Economy Of Scale: TMR Study

ALBANY, N.Y., Sept. 17, 2021 /PRNewswire/ — EV Platform Market: Broad ContoursThe focus on adopting technology frameworks for scaling the production of electric vehicles (EVs) has intensified among OEMs, battery manufacturers, raw material suppliers, and other automotive manufacturers. Automakers in particular consider a scalable EV platform a major proposition for increasing the availability of EVs…

the street news image

Lux Research Identifies Opportunities Beyond Regulatory Compliance In Food Traceability And Transparency

BOSTON, Sept. 16, 2021 /PRNewswire/ — Political, economic, social, and technological factors are all elevating the need for end-to-end food traceability and transparency, and the COVID-19 pandemic served as a force multiplier, according to new insight from Lux Research, a leading provider of tech-enabled research and innovation advisory services. While there is an abundance of reasons…

the street news image

IGT Wins “Technology Provider Of The Year” And “Lottery Product Of The Year” At 2021 International Gaming Awards

LONDON, Sept. 16, 2021 /PRNewswire/ — International Game Technology PLC (“IGT”) (IGT) – Get International Game Technology PLC Report announced today that it won the “Technology Provider of the Year” award and the “Lottery Product of the Year” award in the 2021 International Gaming Awards. In its 14th year, the International Gaming Awards is a global…

the street news image

Exicure To Participate In Upcoming Scientific Conferences

Exicure, Inc. ® (XCUR) – Get Exicure, Inc. Report, a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced participation in the following scientific conferences during the month of September: TIDES USA 2021Poster presentation: “Biodistribution of Spherical Nucleic Acids in the Rat CNS Following ICM and IT Delivery”September 20…

the street news image

I2020 Accelerator Announces The Launch Of Gwynant Therapeutics And Celyn Therapeutics To Develop Novel Small Molecules For Oncology Targets

SAN DIEGO, Sept. 14, 2021 /PRNewswire/ — i2020, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced two new start-up investments together with OrbiMed Advisors. The start-up proceeds will finance new oncology-focused companies: Gwynant Therapeutics and Celyn Therapeutics. The companies will use the proceeds to bring proprietary small molecule…

the street news image

Amazon Announces Plans To Hire 125,000 Employees In Hundreds Of Cities And Towns Across America

Amazon (AMZN) – Get Amazon.com, Inc. Report continues to provide opportunities for full-time and part-time jobs in logistics as it expands its footprint to better serve customers in communities where they live. Today, the company announced that it is providing an additional 125,000 local employment opportunities throughout the U.S., on top of the 40,000 corporate…

the street news image

Andes Wealth Technologies Named Winner In The Risk Tolerance/Client Profiling Category In The WealthManagement.com 2021 Industry Awards

BOSTON, Sept 13, 2021 /PRNewswire/ — Andes Wealth Technologies, an innovative wealth technology company, announced today that it has won the WealthManagement.com 2021 Industry Award in the Risk Tolerance/Client Profiling category. Combining behavioral finance with Risk Tolerance Test, Andes platform takes the risk conversation to a whole new level. Combining behavioral finance with its intuitive Risk…

the street news image

Hummingbird Bioscience Announces US FDA Clearance Of IND For First-in-Human Phase 1 Trial Of HMBD-002 In Patients With Advanced Solid Tumors

HOUSTON and SINGAPORE, Sept. 13, 2021 /PRNewswire/ — Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the U.S. Food and Drug Administration (FDA) has approved the initiation of a Phase 1 clinical trial of HMBD-002, Hummingbird’s anti-VISTA neutralizing antibody. HMBD-002 is being developed for the…